Bosh sahifaGSK β’ BCBA
add
GlaxoSmithKline plc
Yopilish kursi
20Β 290,00Β $
Kunlik diapazon
20Β 500,00Β $ - 20Β 970,00Β $
Yillik diapazon
10Β 000,00Β $ - 22Β 760,00Β $
Bozor kapitalizatsiyasi
114,52Β mlrd USD
OΚ»rtacha hajm
347,00
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (GBP) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 8,62Β mlrd | 6,17% |
Joriy xarajat | 4,37Β mlrd | -4,52% |
Sof foyda | 636,00Β mln | 53,62% |
Sof foyda marjasi | 7,38 | 44,71% |
Har bir ulushga tushum | β | β |
EBITDA | 2,69Β mlrd | 45,43% |
Amaldagi soliq stavkasi | 23,47% | β |
Balans
Jami aktivlari
Jami passivlari
| (GBP) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 3,42Β mlrd | -13,74% |
Jami aktivlari | 61,12Β mlrd | 2,78% |
Jami passivlari | 45,16Β mlrd | -2,62% |
Umumiy kapital | 15,96Β mlrd | β |
Tarqatilgan aksiyalar | 4,01Β mlrd | β |
Narxi/balansdagi bahosi | 4,97Β ming | β |
Aktivlardan daromad | 6,66% | β |
Kapitaldan daromad | 12,13% | β |
Pul aylanmasi
Naqd pulning sof oΚ»zgarishi
| (GBP) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 636,00Β mln | 53,62% |
Operatsiyalardan naqd pul | 2,28Β mlrd | -2,19% |
Sarmoyadan naqd pul | -933,00Β mln | 16,62% |
Moliyadan naqd pul | -856,00Β mln | -1,66% |
Naqd pulning sof oΚ»zgarishi | 448,00Β mln | 19,47% |
BoΚ»sh pul | 222,75Β mln | -88,50% |
Haqida
Tashkil etilgan
27-dek, 2000
Sayt
Xodimlar soni
66Β 841
